
U.S. Premium Bottled Water Market Size, Share, Trend, Industry Analysis Report By Product (Spring Water, Sparkling Water, Mineral Water, Others), By Distribution Channel – Market Forecast, 2025–2034
Description
The U.S. premium bottled water market size is expected to reach USD 12.31 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Premium Bottled Water Market Size, Share, Trend, Industry Analysis Report By Product (Spring Water, Sparkling Water, Mineral Water, Others), By Distribution Channel – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The U.S. premium bottled water market refers to the segment of bottled water positioned as a higher-value product, often distinguished by superior quality, unique sourcing, advanced purification processes, or added health and lifestyle benefits. This market caters to consumers who prioritize taste, purity, brand reputation, and perceived health advantages over standard bottled water options. Growth is fueled by rising health consciousness, where consumers increasingly prefer low-calorie, sugar-free beverages, and by a shift toward functional hydration, including mineral-rich and electrolyte-enhanced offerings. The influence of lifestyle marketing and luxury positioning has also created strong demand, supported by packaging innovations that emphasize sustainability and aesthetics. Increasing interest in natural and sustainably sourced water, combined with transparency in sourcing and production, continues to elevate consumer trust and brand loyalty.
Digital marketing and direct-to-consumer strategies are enabling niche premium brands to reach targeted audiences effectively. The market is also benefiting from demand for on-the-go hydration in urban and active lifestyles, aligning with trends in convenience and wellness. Opportunities lie in expanding premium functional water offerings, introducing eco-friendly packaging solutions, and integrating traceability technologies to meet growing consumer demand for authenticity. Brands that can blend luxury appeal with environmental responsibility and functional benefits are well-positioned to capture long-term market growth.
U.S. Premium Bottled Water Market Report Highlights
By product, the mineral water segment accounted for the largest revenue share of ~41% in 2024 due to its strong positioning as a naturally sourced, nutrient-rich hydration option favored by health-conscious consumers.
Based on distribution channel, the supermarkets & hypermarkets segment held the largest revenue share of ~38% in 2024, driven by their ability to offer diverse premium bottled water selections under one roof, catering to varied consumer tastes.
A few key players include Acqua Panna; CORE Nutrition LLC; Danone Waters of America (Evian); FIJI Water Company LLC; Flow Hydration; Icelandic Glacial, Inc.; Perrier International; Sanpellegrino S.p.A.; The Coca Cola Company; and Voss USA, Inc.
Polaris Market Research has segmented the U.S. premium bottled water market report on the basis of product and distribution channel:
By Product Outlook (Revenue, USD Billion, 2020–2034)
Spring Water
Sparkling Water
Mineral Water
Others
By Distribution Channel Outlook (Revenue, USD Billion, 2020–2034)
Supermarkets & Hypermarkets
Specialty Stores
Online
Others
The U.S. premium bottled water market refers to the segment of bottled water positioned as a higher-value product, often distinguished by superior quality, unique sourcing, advanced purification processes, or added health and lifestyle benefits. This market caters to consumers who prioritize taste, purity, brand reputation, and perceived health advantages over standard bottled water options. Growth is fueled by rising health consciousness, where consumers increasingly prefer low-calorie, sugar-free beverages, and by a shift toward functional hydration, including mineral-rich and electrolyte-enhanced offerings. The influence of lifestyle marketing and luxury positioning has also created strong demand, supported by packaging innovations that emphasize sustainability and aesthetics. Increasing interest in natural and sustainably sourced water, combined with transparency in sourcing and production, continues to elevate consumer trust and brand loyalty.
Digital marketing and direct-to-consumer strategies are enabling niche premium brands to reach targeted audiences effectively. The market is also benefiting from demand for on-the-go hydration in urban and active lifestyles, aligning with trends in convenience and wellness. Opportunities lie in expanding premium functional water offerings, introducing eco-friendly packaging solutions, and integrating traceability technologies to meet growing consumer demand for authenticity. Brands that can blend luxury appeal with environmental responsibility and functional benefits are well-positioned to capture long-term market growth.
U.S. Premium Bottled Water Market Report Highlights
By product, the mineral water segment accounted for the largest revenue share of ~41% in 2024 due to its strong positioning as a naturally sourced, nutrient-rich hydration option favored by health-conscious consumers.
Based on distribution channel, the supermarkets & hypermarkets segment held the largest revenue share of ~38% in 2024, driven by their ability to offer diverse premium bottled water selections under one roof, catering to varied consumer tastes.
A few key players include Acqua Panna; CORE Nutrition LLC; Danone Waters of America (Evian); FIJI Water Company LLC; Flow Hydration; Icelandic Glacial, Inc.; Perrier International; Sanpellegrino S.p.A.; The Coca Cola Company; and Voss USA, Inc.
Polaris Market Research has segmented the U.S. premium bottled water market report on the basis of product and distribution channel:
By Product Outlook (Revenue, USD Billion, 2020–2034)
Spring Water
Sparkling Water
Mineral Water
Others
By Distribution Channel Outlook (Revenue, USD Billion, 2020–2034)
Supermarkets & Hypermarkets
Specialty Stores
Online
Others
Table of Contents
123 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. U.S. Neurovascular Intervention Devices Market Insights
- 4.1. U.S. Neurovascular Intervention Devices Market – Market Snapshot
- 4.2. U.S. Neurovascular Intervention Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Neurovascular Diseases
- 4.2.1.2. Aging Population Increasing Prevalence of Cerebrovascular Disorders
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Device Costs and Procedural Complexity
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. U.S. Neurovascular Intervention Devices Market Trends
- 4.6. Value Chain Analysis
- 5. U.S. Neurovascular Intervention Devices Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. U.S. Neurovascular Intervention Devices Market, by Product, 2020-2034 (USD Billion)
- 5.3. Embolic Coils
- 5.3.1. U.S. Neurovascular Intervention Devices Market, by Embolic Coils, by Country, 2020-2034 (USD Billion)
- 5.4. Carotid Stents
- 5.4.1. U.S. Neurovascular Intervention Devices Market, by Carotid Stents, by Country, 2020-2034 (USD Billion)
- 5.5. Intracranial Stents
- 5.5.1. U.S. Neurovascular Intervention Devices Market, by Intracranial Stents, by Country, 2020-2034 (USD Billion)
- 5.6. Neurovascular Thrombectomy
- 5.6.1. U.S. Neurovascular Intervention Devices Market, by Neurovascular Thrombectomy, by Country, 2020-2034 (USD Billion)
- 5.7. Embolic Protection Devices
- 5.7.1. U.S. Neurovascular Intervention Devices Market, by Embolic Protection Devices, by Country, 2020-2034 (USD Billion)
- 5.8. Flow Diverters Devices
- 5.8.1. U.S. Neurovascular Intervention Devices Market, by Flow Diverters Devices, by Country, 2020-2034 (USD Billion)
- 5.9. Intrasaccular Devices
- 5.9.1. U.S. Neurovascular Intervention Devices Market, by Intrasaccular Devices, by Country, 2020-2034 (USD Billion)
- 5.10. Liquid Embolic
- 5.10.1. U.S. Neurovascular Intervention Devices Market, by Liquid Embolic, by Country, 2020-2034 (USD Billion)
- 5.11. Balloons
- 5.11.1. U.S. Neurovascular Intervention Devices Market, by Balloons, by Country, 2020-2034 (USD Billion)
- 5.12. Stent Retrievers
- 5.12.1. U.S. Neurovascular Intervention Devices Market, by Stent Retrievers, by Country, 2020-2034 (USD Billion)
- 6. U.S. Neurovascular Intervention Devices Market, by Technique
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. U.S. Neurovascular Intervention Devices Market, by Technique, 2020-2034 (USD Billion)
- 6.3. Neurothrombectomy Procedure
- 6.3.1. U.S. Neurovascular Intervention Devices Market, by Neurothrombectomy Procedure, by Country, 2020-2034 (USD Billion)
- 6.4. Cerebral Angiography
- 6.4.1. U.S. Neurovascular Intervention Devices Market, by Cerebral Angiography, by Country, 2020-2034 (USD Billion)
- 6.5. Stenting
- 6.5.1. U.S. Neurovascular Intervention Devices Market, by Stenting, by Country, 2020-2034 (USD Billion)
- 6.6. Coiling Procedures
- 6.6.1. U.S. Neurovascular Intervention Devices Market, by Coiling Procedures, by Country, 2020-2034 (USD Billion)
- 6.7. Flow Disruption
- 6.7.1. U.S. Neurovascular Intervention Devices Market, by Flow Disruption, by Country, 2020-2034 (USD Billion)
- 7. U.S. Neurovascular Intervention Devices Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. U.S. Neurovascular Intervention Devices Market, by End User, 2020-2034 (USD Billion)
- 7.3. Hospitals
- 7.3.1. U.S. Neurovascular Intervention Devices Market, by Hospitals, by Country, 2020-2034 (USD Billion)
- 7.4. Ambulatory Surgical Centers
- 7.4.1. U.S. Neurovascular Intervention Devices Market, by Ambulatory Surgical Centers, by Country, 2020-2034 (USD Billion)
- 7.5. Other End Users
- 7.5.1. U.S. Neurovascular Intervention Devices Market, by Other End Users, by Country, 2020-2034 (USD Billion)
- 8. U.S. Neurovascular Intervention Devices Market, by Country
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. U.S. Neurovascular Intervention Devices Market Assessment, By Country, 2020-2034 (USD Billion)
- 8.2.2. U.S. Neurovascular Intervention Devices Market
- 8.2.2.1. U.S.: Neurovascular Intervention Devices Market, by Product, 2020-2034 (USD Billion)
- 8.2.2.2. U.S.: Neurovascular Intervention Devices Market, by Technique, 2020-2034 (USD Billion)
- 8.2.2.3. U.S.: Neurovascular Intervention Devices Market, by End User, 2020-2034 (USD Billion)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Acandis GmbH
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Balt USA
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Inari Medical
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Johnson & Johnson
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Medtronic plc
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Rapid Medical
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Stryker Corporation
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Terumo Corporation
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. VESALIO
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Zeta Surgical
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Penumbra
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Q’Apel Medical, Inc.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.